We have analysis results for new ADC pharmaceuticals under development and for marketed products, including Daiichi Sankyo's Enhertu!
"ADC analysis and bioanalysis" is a service that allows for the simultaneous analysis of low molecular weight compounds as well as high molecules such as proteins and antibodies. This service is particularly useful for startup companies and pharmaceutical companies developing biopharmaceuticals (including ADCs), where there is a need to establish new analytical techniques alongside product development. Mithra has extensive experience and solid technical capabilities in the field of bioanalysis, and we welcome inquiries even at the idea stage or early development phase. Please feel free to contact us. [Features] ■ Accumulated technology for integrated development of low molecular and biopharmaceuticals over many years ■ Particularly rich insights in ADC analysis are highly valued by ADC development companies in Taiwan and abroad *For more details, please download the PDF or feel free to contact us.
Inquire About This Product
basic information
【Analysis Content】 ■ ADC Analysis ■ Bioanalysis ■ Simultaneous Analysis of Synthetic Pharmaceuticals and Biopharmaceuticals *For more details, please download the PDF or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Purpose】 ■Supplementing the services of Mycenax, for which we serve as the exclusive agent ■Support is available for analytical testing and PK bioanalysis *For more details, please download the PDF or feel free to contact us.
catalog（1）
Download All Catalogs
News about this product（1）
![[New] CMO/CDMO EXPO (Formulation Development and Contract Manufacturing Exhibition) | Interphex Week Tokyo](https://image.mono.ipros.com/public/news/image/1/2049121/IPROS3752377957217907680.png?w=280&h=280)
Company information
Libra Medicina Co., Ltd. aims to contribute to the improvement of health and quality of life for people around the world by being involved in the creation of innovative pharmaceuticals and medical devices through development support services and licensing activities, delivering hope to patients suffering from serious diseases.
